NextPlat (NXPL) risk factors
Item 1A of every NextPlat Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors30 risks30 new113 dropped
NextPlat faces significant ongoing net losses and reliance on a single pharmaceutical supplier for 98% of purchases. The company struggles with Nasdaq listing compliance, prompting plans for a reverse stock split. Macroeconomic pressures and inflation continue to threaten profit margins and operating costs.
Filed Mar 31, 2026 - FY2024 10-K risk factors113 risks
NextPlat relies heavily on Amazon and Alibaba marketplaces, generating 32.8% of 2024 sales on Amazon and 67% internationally. The company faces ongoing net losses, posting a $23.1 million net loss in 2024 and an accumulated deficit of $49.0 million. Operations span diverse sectors including pharmacy services, e-commerce, and satellite tracking device development.
Filed Mar 24, 2025